Sudhaker D Rao
Overview
Explore the profile of Sudhaker D Rao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
614
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Arjunan D, Minisola S, Rao S, Bhadada S
Best Pract Res Clin Endocrinol Metab
. 2025 Feb;
39(2):101980.
PMID: 39920032
Primary hyperparathyroidism (PHPT), the third most common endocrine disorder, was so eloquently described first by Fuller Albright as a polymorphic condition in his classic paper and monograph as early as...
2.
Yadav R, Oravec D, Drost J, Flynn M, Divine G, Rao S, et al.
Eur J Radiol
. 2025 Jan;
183:111925.
PMID: 39832416
Vertebral fractures are a common and debilitating consequence of osteoporosis. Bone mineral density (BMD), measured by dual energy x-ray absorptiometry (DXA), is the clinical standard for assessing overall bone quantity...
3.
Yadav R, Oravec D, Cushman T, Rao S, Yeni Y
Bone
. 2024 Dec;
192():117368.
PMID: 39672218
Bone fractures due to osteoporosis are a significant problem. Limited accuracy of standard bone mineral density (BMD) for fracture risk assessment, combined with low adherence to bone health screening precludes...
4.
Sharma S, Shankar V, Rajender S, Mithal A, Rao S, Chattopadhyay N
Front Endocrinol (Lausanne)
. 2024 Sep;
15:1426490.
PMID: 39257899
Background And Aims: Reduced bone mineral density (BMD) and microarchitectural deterioration contribute to increased fracture risk. Although the effects of anti-fracture medications (AFMs) on BMD are well-documented, their impact on...
5.
Johnson G, Griffin L, Qiu S, Rao S
JBMR Plus
. 2024 Aug;
8(9):ziae097.
PMID: 39135632
Atypical femur fractures (AFFs) are a well-established complication of long-term bisphosphonate (BP) therapy, but their pathogenesis is not fully understood. Although many patients on long-term BP therapy have severe suppression...
6.
Demay M, Pittas A, Bikle D, Diab D, Kiely M, Lazaretti-Castro M, et al.
J Clin Endocrinol Metab
. 2024 Jun;
109(8):1907-1947.
PMID: 38828931
Background: Numerous studies demonstrate associations between serum concentrations of 25-hydroxyvitamin D (25[OH]D) and a variety of common disorders, including musculoskeletal, metabolic, cardiovascular, malignant, autoimmune, and infectious diseases. Although a causal...
7.
Qiu S, Dhaliwal R, Divine G, Warner E, Rao S
J Bone Miner Res
. 2024 Mar;
39(4):417-424.
PMID: 38477744
Bone histomorphometric endpoints in transilial biopsies may be associated with an increased risk of atypical femoral fracture (AFF) in patients with osteoporosis who take antiresorptives, including bisphosphonates (BPs). One way...
8.
Rao S, Malhotra B, Bhadada S
Endocrinology
. 2023 Dec;
165(2).
PMID: 38104244
No abstract available.
9.
Shah V, Qui S, Stoneback J, Qamar L, Ferguson V, Kohrt W, et al.
JBMR Plus
. 2023 Nov;
7(11):e10831.
PMID: 38025041
Compromised bone structural and mechanical properties are implicated in the increased fracture risk in type 1 diabetes (T1D). We investigated bone structure and turnover by histomorphometry in postmenopausal women with...
10.